Literature DB >> 35411081

Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells.

Sarah B Crist1,2, Travis Nemkov3, Ruth F Dumpit4, Jinxiang Dai1, Stephen J Tapscott4,5,6, Lawrence D True7,8, Alexander Swarbrick9,10, Lucas B Sullivan4, Peter S Nelson4,5,7,8,11, Kirk C Hansen3, Cyrus M Ghajar12,13.   

Abstract

Skeletal muscle has long been recognized as an inhospitable site for disseminated tumour cells (DTCs). Yet its antimetastatic nature has eluded a thorough mechanistic examination. Here, we show that DTCs traffic to and persist within skeletal muscle in mice and in humans, which raises the question of how this tissue suppresses colonization. Results from mouse and organotypic culture models along with metabolomic profiling suggested that skeletal muscle imposes a sustained oxidative stress on DTCs that impairs their proliferation. Functional studies demonstrated that disrupting reduction-oxidation homeostasis via chemogenetic induction of reactive oxygen species slowed proliferation in a more fertile organ: the lung. Conversely, enhancement of the antioxidant potential of tumour cells through ectopic expression of catalase in the tumour or host mitochondria allowed robust colonization of skeletal muscle. These findings reveal a profound metabolic bottleneck imposed on DTCs and sustained by skeletal muscle. A thorough understanding of this biology could reveal previously undocumented DTC vulnerabilities that can be exploited to prevent metastasis in other more susceptible tissues.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35411081     DOI: 10.1038/s41556-022-00881-4

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.213


  63 in total

1.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

2.  Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.

Authors:  Mark R Sullivan; Katherine R Mattaini; Emily A Dennstedt; Anna A Nguyen; Sharanya Sivanand; Montana F Reilly; Katrina Meeth; Alexander Muir; Alicia M Darnell; Marcus W Bosenberg; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Cell Metab       Date:  2019-03-21       Impact factor: 27.287

3.  PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.

Authors:  Fanny Dupuy; Sébastien Tabariès; Sylvia Andrzejewski; Zhifeng Dong; Julianna Blagih; Matthew G Annis; Atilla Omeroglu; Dongxia Gao; Samuel Leung; Eitan Amir; Mark Clemons; Adriana Aguilar-Mahecha; Mark Basik; Emma E Vincent; Julie St-Pierre; Russell G Jones; Peter M Siegel
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

4.  Asparagine bioavailability governs metastasis in a model of breast cancer.

Authors:  Simon R V Knott; Elvin Wagenblast; Showkhin Khan; Sun Y Kim; Mar Soto; Michel Wagner; Marc-Olivier Turgeon; Lisa Fish; Nicolas Erard; Annika L Gable; Ashley R Maceli; Steffen Dickopf; Evangelia K Papachristou; Clive S D'Santos; Lisa A Carey; John E Wilkinson; J Chuck Harrell; Charles M Perou; Hani Goodarzi; George Poulogiannis; Gregory J Hannon
Journal:  Nature       Date:  2018-02-07       Impact factor: 49.962

5.  Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

Authors:  Gaorav P Gupta; Don X Nguyen; Anne C Chiang; Paula D Bos; Juliet Y Kim; Cristina Nadal; Roger R Gomis; Katia Manova-Todorova; Joan Massagué
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

6.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

7.  Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells.

Authors:  Ilaria Elia; Dorien Broekaert; Stefan Christen; Ruben Boon; Enrico Radaelli; Martin F Orth; Catherine Verfaillie; Thomas G P Grünewald; Sarah-Maria Fendt
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

8.  Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.

Authors:  Matteo Rossi; Steve Stegen; Dorien Broekaert; Ginevra Doglioni; Marit van Gorsel; Ilaria Elia; Ruben Boon; Carmen Escalona-Noguero; Sophie Torrekens; Catherine Verfaillie; Erik Verbeken; Geert Carmeliet; Sarah-Maria Fendt
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

9.  Metabolic heterogeneity confers differences in melanoma metastatic potential.

Authors:  Alpaslan Tasdogan; Brandon Faubert; Vijayashree Ramesh; Jessalyn M Ubellacker; Bo Shen; Ashley Solmonson; Malea M Murphy; Zhimin Gu; Wen Gu; Misty Martin; Stacy Y Kasitinon; Travis Vandergriff; Thomas P Mathews; Zhiyu Zhao; Dirk Schadendorf; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nature       Date:  2019-12-18       Impact factor: 49.962

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.